Cancer cells that enter a distant organ are inactivated because they are unable to bind integrin-β1 and trigger the activation of FAK [269,281], and because they encounter unfavorable biochemical and mechanical signals when they reach the secondary target site. Here, PTK2 is linked to cancer.